Tissue transglutaminase: an enzyme with a split personality.
about
Transglutaminases: nature's biological gluesThe nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.The redox state of transglutaminase 2 controls arterial remodelingThe mixed lineage kinase DLK is oligomerized by tissue transglutaminase during apoptosisInterleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIaUsing FLIM-FRET to measure conformational changes of transglutaminase type 2 in live cellsThe Actin cross-linking domain of the Vibrio cholerae RTX toxin directly catalyzes the covalent cross-linking of actinIn vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxinDetection of in situ activation of transglutaminase during apoptosis: correlation with the cell cycle phase by multiparameter flow and laser scanning cytometry.Characterization of sea urchin transglutaminase, a protein regulated by guanine/adenine nucleotides.Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA.Effect of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures.Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270.Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis.Pressure load: the main factor for altered gene expression in right ventricular hypertrophy in chronic hypoxic rats.Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.Delivering the message: epimorphin and mammary epithelial morphogenesis.Alpha1B-adrenoceptor signaling and cell motility: GTPase function of Gh/transglutaminase 2 inhibits cell migration through interaction with cytoplasmic tail of integrin alpha subunits.Transglutaminase 2 and its role in pulmonary fibrosis.Transglutaminase 2: a molecular Swiss army knife.Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation.Transglutaminase 2 inhibitors and their therapeutic role in disease states.Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ light chain enhancer of activated B cells (NFκB) signaling controls basal and DNA damage-induced transglutaminase 2 expression.Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiationTissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.Senescence and programmed cell death in plants: polyamine action mediated by transglutaminase.Transglutaminase 2 as a biomarker of osteoarthritis: an update.Recent advances in the development of tissue transglutaminase (TG2) inhibitors.Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.Biotechnological applications of transglutaminasesThe transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.Microarray analysis uncovers retinoid targets in human bronchial epithelial cells.Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.Retinoids and glucocorticoids target common genes in hippocampal HT22 cells.Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides.Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.Inhibition of tissue transglutaminase sensitizes TRAIL-resistant lung cancer cells through upregulation of death receptor 5.
P2860
Q24534936-F162E2B0-553B-485C-9B7C-E1313B9AE1D4Q24815528-8E6D9971-004E-4EB6-90AD-D040E79F57EFQ27325795-3E487F8A-8D33-4049-84FA-DF481AEA585EQ28142457-18B4C275-970F-46D9-BFD5-877F4F13E2A6Q28343531-54A8C35C-6DFE-4DF0-95E6-0EE1F06BCC50Q28483257-D21BA57A-5011-4B68-A12F-9132E0A7843EQ28485712-F34681CD-26B7-468C-A758-F7D5AD87BA5DQ28485730-1560576D-A6D9-4458-B5E8-75F8C820579BQ30858355-198AB23E-435D-4528-9D19-0B5F16798599Q31114157-DB1B3AFA-FBF2-47E3-9587-429A188F0466Q31160300-4F352EC4-E172-4021-B6A5-517126679B56Q33240965-B6D0531C-473A-4CAB-8779-70960BF55BB8Q33385701-F8A3EBCE-82F2-4932-A384-29A482ABC91DQ33476870-1177C496-10F2-492B-A370-6405AF062403Q33493113-6F7A7584-7431-4F5B-9CE6-941004A5275EQ33596027-52509DA9-42F6-444A-8162-715167D01976Q33796637-C542B7BF-D019-42EA-A2D5-D1D7917D1EABQ33799573-50DA3C98-BA3E-45CE-AE82-9DFE39FE7391Q34103330-1DFC15F5-BD86-400D-A2B6-2B604A9D7FEEQ34329442-82FBA162-3506-4E18-B158-3F3690FE7526Q35527871-93CA52DB-A65E-4F32-8F64-14D191B3D6EDQ35693361-49A6776D-D44C-4946-A2BF-AB1C66169AFCQ35697155-7EE9A30D-4FCB-4B6F-9353-E1CE2A91BC93Q35989247-D6AFEBF7-C02A-4AFE-ACD2-6AE7D54E51F4Q36003028-324BEFF6-196E-4B00-9A32-97421EA3718CQ36711191-24945815-2579-4E43-84E1-0A23FC46721DQ36916421-4740E7A0-FF14-488F-88D8-5E2748D7EB8AQ37266151-A48094C1-4814-4A41-A9AE-DFC3D06F679DQ37700254-870159B0-D8C1-48BE-AE68-B8D84EEDEF5EQ37964507-E18860EE-8590-482F-98FF-59C755E6A457Q37967368-7901347F-FF77-4FB7-A206-9D60229F02BEQ38065965-691366F7-3C47-4D27-A91F-81BD174A9AFCQ38223682-44057AF5-5DF6-42B9-95C8-84318A1A0C4DQ38294813-E02CE4F2-DA5A-44A3-95DF-437AC998AAC4Q38351948-9612F914-F400-48A1-995B-24BA8746FDDDQ38937553-977494D0-AB1D-4140-B0BD-01863966B95EQ39196761-CD35DB9B-0137-4A0C-A938-42934F98E37AQ39449371-5D2B3203-CAC8-4603-854E-2A15F533E4F1Q39552139-6BB300A0-92FF-44FA-ABD3-76650669D042Q39706496-37631803-FAF9-451B-866B-DC87DA85524E
P2860
Tissue transglutaminase: an enzyme with a split personality.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tissue transglutaminase: an enzyme with a split personality.
@ast
Tissue transglutaminase: an enzyme with a split personality.
@en
type
label
Tissue transglutaminase: an enzyme with a split personality.
@ast
Tissue transglutaminase: an enzyme with a split personality.
@en
prefLabel
Tissue transglutaminase: an enzyme with a split personality.
@ast
Tissue transglutaminase: an enzyme with a split personality.
@en
P1476
Tissue transglutaminase: an enzyme with a split personality.
@en
P304
P356
10.1016/S1357-2725(99)00045-X
P577
1999-08-01T00:00:00Z